MAVS and viral myocarditis: Another research found metalloproteinase domain 9 (ADAM9) bind to MDA5 and promoted (MAVS), and thereby induced type I interferon production during encephalomyocarditis virus infection, which provides a therapeutic target for viral myocarditis (64).